Overview of Dr. Mulvey
Lymphoma Program
Office
1300 York Avenue
New York, NY 10021
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2018 - 2021- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
New York Medical CollegeClass of 2015
Certifications & Licensure
NY State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsFollicular lymphoma grade 3B: low grade, high grade or should we skip the grade?Erin Mulvey, John P Leonard
Haematologica. 2023-09-01 - 13 citationsMulticenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen
Blood. 2023-05-04 - 2 citationsInhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma.Florencia Cayrol, Maria V Revuelta, Mercedes Debernardi, Alejandra Paulazo, Jude M Phillip
Molecular Cancer Therapeutics. 2022-09-06
Press Mentions
Lymphoma Research Foundation Funds 29 Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity InitiativeMarch 31st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
